References
- Harron DWG, Brogden RN, Faulds D, Fitton A. Cibenzoline a review of its pharmacological properties and therapeutic potential in arrhythmias. Drugs 1992; 43(5)734–759
- Paelinck BP, De Raedt H, Conraads V. Blurred vision, left bundle-branch block and cardiac failure. Acta Cardiol 2001; 56: 39–40
- Aoyama N, Sasaki T, Yoshida M, Suzuki K, Matsuyama K, Aizaki T, Izumi T, Kondo R, Kamijo Y, Soma K, Ohwada T. Effect of charcoal hemoperfusion on clearance of cibenzoline succinate (Cifenline) poisoning. J Toxicol Clin Toxicol 1999; 37(4)505–508
- Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31–41
- Kostis JB, Davis D, Kluger J, Aogaichi K, Smith M. Cifenline in the short-term treatment of patients with ventricular premature complexes: A double blind placebo-controlled study. J Cardiovasc Pharmacol 1989; 14: 88–95
- Demedts P, Wauters A, Franck F, Neels H. Simultaneous determination of lidocaine, bupivacaine, and their two main metabolites using gas chromatography and nitrogen-phosphorus detector: selection of a stationary phase and chromatographic conditions. Ther Drug Monit 1996; 18: 208–211
- Watelle M, Demedts P, Franck F, De Deyn PP, Wauters A, Neels H. Analysis of the antiepileptic phenyltriazine compound lamotrigine using gas chromatography with nitrogen phophorus detection. Ther Drug Monit 1997; 19: 460–464
- Verpooten GA, De Broe ME. Combined hemoperfusion-hemodialysis in severe poisoning: kinetics of drug extraction. Resuscitation 1984; 1: 275–289
- Vale JA, Rees AJ, Widdop B, Goulding R. Use of charcoal haemoperfusion in the management of severely poisoned patients. Br Med J 1975; 1: 5–9
- Gwilt PR, Perrier D. Plasma protein binding and distribution characteristics of drugs and indices of their hemodialyzibility. Clin Pharmacol Ther 1978; 24: 154–161